Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
Graham put his pain down to acid reflux then doctors told him it was cancer and he had a year to live. Now thanks to an astonishing new drug his tumour has halved and it’s helping breast cancer patients too. His doctor says: ‘It’s so exciting!’
When Graham Caveney was diagnosed with stage-four oesophageal cancer in 2022, doctors gave him just over a year…
GLP-1s, taste and what’s happening to our diets
Inside the DIY Ozempic boom Americans are cooking up their own Ozempic—here’s why that’s alarming. Jess Loren remembers…
OncoNano Taps Veteran Biopharmaceutical Leader as Its New Chief Operating Officer » Dallas Innovates
OncoNano COO Brent Sorrells [Composite image; source: OncoNano Medicine/DI Studio] Dallas cancer therapeutic company OncoNano Medicine has named…
Trump seeks lower prices for Wegovy, Zepbound
President Donald Trump announces plan to expand IVF access President Donald Trump announced a plan to expand IVF…
Lower drug prices for Americans! Trump seals deal with AstraZeneca; some medicines at discounts of up to 80%
US President Donald Trump on Friday announced reaching a deal with AstraZeneca, which would lower the cost of…
50 European corporates backing startups on the path to growth, innovation, and global impact
Across Europe, big companies are becoming strong backers of startup innovation, and corporate venturing is widely used as…
AstraZeneca to list shares in New York while keeping London listing
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
AstraZeneca switches to direct US listing, keeps UK listing
(Reuters) -AstraZeneca said on Monday it would now directly list its shares on the New York Stock Exchange,…
Sweden Unites Major Corporations to Launch Sferical AI for Enhanced Industry Competitiveness, ETTelecom
AstraZeneca, Ericsson, Saab, SEB and Wallenberg Investments will jointly launch an artificial intelligence company to develop advanced AI…